Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.05.2022 | Case report

Antineoplastics

No therapeutic response: 4 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hernandez-Boluda JC, et al. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplantation 57: 416-422, No. 3, Mar 2022. Available from: URL: http://doi.org/10.1038/s41409-021-01553-x Hernandez-Boluda JC, et al. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplantation 57: 416-422, No. 3, Mar 2022. Available from: URL: http://​doi.​org/​10.​1038/​s41409-021-01553-x
Metadaten
Titel
Antineoplastics
No therapeutic response: 4 case reports
Publikationsdatum
01.05.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-15800-8

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Dexamethasone

Case report

Remdesivir

Case report

Erlotinib

Case report

Multiple drugs

Case report

Multiple drugs